ORIX (TSE:8591): Is There Upside Left as Shares Trade Below Fair Value?

ORIX (TSE:8591) shares have seen some subtle shifts recently, with the stock delivering a 1% move over the last day and a slightly negative performance over the past week. Investors may be closely watching these changes for potential opportunities given the broader market dynamics.

See our latest analysis for ORIX.

ORIX’s momentum has gradually picked up, with a strong 11% year-to-date share price return and a striking 20% total shareholder return over the past year. This suggests investors are recognizing both ongoing resilience and longer-term growth. The latest price action adds to an impressive multi-year track record, which reinforces the company’s appeal for those seeking steady compounding in a shifting market environment.

If you’re interested in what else could be driving strong returns lately, now’s a great chance to broaden your opportunity set and discover fast growing stocks with high insider ownership

But with shares still trading at a notable discount to analyst targets and robust fundamentals in play, the real question is whether ORIX is undervalued at today’s levels or if the market has already accounted for its upside.

Most Popular Narrative: 10% Undervalued

With ORIX’s fair value estimate at ¥4166, about 10% above its last close, the stage is set for a debate over just how much upside remains according to the narrative consensus.

ORIX's ongoing capital recycling strategy, highlighted by portfolio optimization through divesting non-core assets (for example, the sale of Greenko and ORIX Asset Management & Loan Services), and reallocating proceeds into higher-growth areas such as green energy and private asset management, is expected to drive higher ROE and long-term net income growth.

Read the complete narrative.

Curious what really underpins this optimistic price target? The most discussed part of the narrative is a set of surprising profit and margin growth forecasts that could reshape expectations. Want to know which bold assumptions and sector trends are feeding this valuation? Read on to uncover the story behind the numbers.

Result: Fair Value of ¥4166 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, continued reliance on one-off asset sales and persistent macroeconomic uncertainties could put pressure on ORIX’s earnings stability and challenge the bullish outlook.

Find out about the key risks to this ORIX narrative.

Build Your Own ORIX Narrative

If you see things differently or want to dig into your own analysis, you can build a narrative using the latest data in just a few minutes. So why not Do it your way?

A great starting point for your ORIX research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more smart investment ideas?

Don't let tomorrow's winners pass you by. The Simply Wall Street Screener connects you to fresh opportunities, so you can act ahead of the crowd and stay in control.

• Boost your portfolio's potential by scanning these 838 undervalued stocks based on cash flows that are priced for significant upside and strong fundamentals.
• Tap into the future of healthcare by targeting innovation leaders through these 34 healthcare AI stocks who are setting new standards in AI-driven medicine.
• Generate steady income and outpace inflation by reviewing these 24 dividend stocks with yields > 3% with yields above 3% and reliable payouts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com